The involved clinics include:
• Chico-based Orthopedic Associates of Northern California — $815,794
• Redlands, Calif.-based San Bernardino Medical Orthopaedic Group, DBA Arrowhead Orthopaedics — $971,903
• Reno (Nev.) Orthopaedic Clinic — $602,335
Here are five things to know:
1. The three orthopedic clinics allegedly billed federal and state healthcare programs for re-imported osteoarthritis medications, called viscosupplements.
2. Allegedly, the clinics bought discounted viscosupplements that were re-imported from foreign countries. They then billed state and federal healthcare programs for reimbursements, even though the re-imported viscosupplements did not qualify as reimbursable.
3. The federal government claimed that since the products were re-imported, they could have been altered or stored inappropriately.
4. The lawsuit came to fruition after a senior musculoskeletal specialty manger at Sanofi S.A. — a manufacturer of viscosupplements — filed it via the False Claims Act.
5. The court has not yet determined any liability; the settlement is just based on allegations.
More articles on practice management:
FDA regulation, insurance coverage: Dr. Raj N. Sureja talks challenges in regenerative medicine
OrthoCarolina’s workplace wellness program ranked 23rd in US: 4 notes
Medicare sets new safety goal for hospitals to lower readmissions: 3 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
